Contact this trialFirst, we need to learn more about you.
CDK4/6 Inhibitor
ZEN003694 + Abemaciclib for Cancer
Recruiting1 awardPhase 1
Los Angeles, California
This trial tests safety and best dose of a drug combo for treating metastatic or unresectable cancer. ZEN003694 and abemaciclib may prevent growth of tumor cells.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.